NCT06785233View on ClinicalTrials.gov

Endoscopic Treatment of Overweight and Mild Obesity with ORBERA365

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2025

Study Completion Date

February 28, 2026

Conditions
ObesityObesity, Morbid
Interventions
DEVICE

Non-Adjustable Intragastric Balloon

Weight Loss with a 12-Month Non-Adjustable Intragastric Balloon is More Effective Compared to a 6-Month Balloon.

DEVICE

ORBERA365

endoscopic treatment of overweight and mild obesity using a 12-month non-adjustable intragastric balloon

Trial Locations (1)

09060-870

RECRUITING

Faculdade ABC, Santo André

All Listed Sponsors
lead

Kaiser Clinic and Hospital

OTHER